x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
Delaware
|
20-5657551
|
(State
or other jurisdiction of incorporation of organization)
|
(I.R.S.
Employer Identification Number)
|
Page
|
||
PART
I.
|
FINANCIAL
INFORMATION
|
|
Item
1.
|
Financial
Statements (Unaudited)
|
|
Condensed
Consolidated Balance Sheets as of September 30, 2007 and December
31,
2006
|
1
|
|
Condensed
Consolidated Statements of Income for the Three and Nine-Month Periods
Ended September 30, 2007 and 2006
|
2
|
|
Condensed
Consolidated Statements of Cash Flows for the Nine-Month Periods
Ended
September 30, 2007 and 2006
|
3
|
|
Notes
to Condensed Consolidated Financial Statements
|
4
|
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
12
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
14
|
Item
4.
|
Controls
and Procedures
|
14
|
PART
II.
|
OTHER
INFORMATION
|
|
Item
1.
|
Legal
Proceedings
|
15
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
15
|
Item
3.
|
Defaults
upon Senior Securities
|
15
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
15
|
Item
5.
|
Other
Information
|
15
|
Item
6.
|
Exhibits
|
15
|
16
|
PART I. |
FINANCIAL
INFORMATION
|
Item 1. |
Financial
Statements
|
September 30,
2007
|
December
31,
2006 |
||||||
(Unaudited)
|
(Note
B)
|
||||||
Assets
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
33,506
|
$
|
24,405
|
|||
Short-term
investments
|
-
|
8,000
|
|||||
Accounts
receivable, net of allowances for doubtful accounts of
$150
|
16,330
|
16,724
|
|||||
Inventories
|
343
|
203
|
|||||
Deferred
income taxes
|
4,043
|
4,972
|
|||||
Prepaid
expenses and other current assets
|
1,256
|
1,916
|
|||||
Total
current assets
|
55,478
|
56,220
|
|||||
Equipment,
net of accumulated depreciation of $10,588 and $8,845,
respectively
|
4,889
|
4,051
|
|||||
Goodwill
|
2,119
|
2,119
|
|||||
Other
intangible assets, net of accumulated amortization of $1,289 and
$1,205,
respectively
|
1,092
|
1,156
|
|||||
Deferred
income taxes
|
2,261
|
885
|
|||||
Other
assets
|
2,473
|
1,229
|
|||||
Total
assets
|
$
|
68,312
|
$
|
65,660
|
|||
Liabilities
and Shareholders’ Equity
|
|||||||
Current
liabilities:
|
|||||||
Short-term
debt
|
$
|
1,330
|
$
|
-
|
|||
Accounts
payable
|
4,921
|
7,632
|
|||||
Accrued
liabilities
|
4,015
|
9,873
|
|||||
Total
current liabilities
|
10,266
|
17,505
|
|||||
Other
liabilities
|
1,274
|
500
|
|||||
Total
liabilities
|
11,540
|
18,005
|
|||||
Shareholders'
equity:
|
|||||||
Common
stock, $.01 par value, 40,000,000 shares authorized, 22,400,602 and
22,086,728 shares issued, respectively
|
223
|
221
|
|||||
Additional
paid-in capital
|
110,259
|
103,122
|
|||||
Accumulated
deficit
|
(54,124
|
)
|
(56,044
|
)
|
|||
Accumulated
other comprehensive income
|
142
|
79
|
|||||
Nil
coupon perpetual loan notes
|
272
|
277
|
|||||
Total
shareholders' equity
|
56,772
|
47,655
|
|||||
Total
liabilities and shareholders' equity
|
$
|
68,312
|
$
|
65,660
|
Three Months Ended
September 30
|
Nine Months Ended
September 30
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Net
sales
|
$
|
15,246
|
$
|
20,173
|
$
|
47,718
|
$
|
57,053
|
|||||
Costs
and expenses:
|
|||||||||||||
Cost
of sales
|
8,018
|
10,042
|
26,058
|
29,210
|
|||||||||
Selling,
general and administrative
|
5,656
|
6,106
|
18,125
|
17,569
|
|||||||||
Research
and development
|
541
|
617
|
1,652
|
1,467
|
|||||||||
14,215
|
16,765
|
45,835
|
48,246
|
||||||||||
Operating
income
|
1,031
|
3,408
|
1,883
|
8,807
|
|||||||||
Interest
income
|
417
|
268
|
1,253
|
665
|
|||||||||
Other
income (expense)
|
50
|
(14
|
)
|
(21
|
)
|
(33
|
)
|
||||||
Income
before taxes
|
1,498
|
3,662
|
3,115
|
9,439
|
|||||||||
Income
tax expense
|
(571
|
)
|
(1,602
|
)
|
(1,114
|
)
|
(4,071
|
)
|
|||||
Net
income
|
$
|
927
|
$
|
2,060
|
$
|
2,001
|
$
|
5,368
|
|||||
Net
income per Common Share:
|
|||||||||||||
Basic
|
$
|
0.04
|
$
|
0.09
|
$
|
0.09
|
$
|
0.25
|
|||||
Diluted
|
$
|
0.04
|
$
|
0.09
|
$
|
0.08
|
$
|
0.22
|
|||||
Weighted-average
number of Common Shares outstanding:
|
|||||||||||||
Basic
|
22,390,000
|
21,721,000
|
22,239,000
|
21,348,000
|
|||||||||
Diluted
|
24,769,000
|
24,123,000
|
24,718,000
|
24,045,000
|
Nine Months Ended
September 30
|
|||||||
2007
|
2006
|
||||||
Operating
activities
|
|||||||
Net
cash (used in) provided by operating activities
|
$
|
(1,127
|
)
|
$
|
3,426
|
||
Investing
activities
|
|||||||
Sales
(purchases) of short-term investments
|
8,000
|
(4,000
|
)
|
||||
Purchases
of equipment and patents
|
(2,617
|
)
|
(1,699
|
)
|
|||
Net
cash provided by (used in) investing activities
|
5,383
|
(5,699
|
)
|
||||
Financing
activities
|
|||||||
Proceeds
from short-term borrowings
|
1,330
|
-
|
|||||
Proceeds
from exercise of stock options
|
870
|
3,058
|
|||||
Issuance
of deferred shares of stock
|
1,130
|
-
|
|||||
Income
tax benefit from exercise of stock options
|
1,451
|
4,465
|
|||||
Net
cash provided by financing activities
|
4,781
|
7,523
|
|||||
Effect
of exchange rate fluctuations on cash
|
64
|
84
|
|||||
Net
increase in cash and cash equivalents
|
9,101
|
5,334
|
|||||
Cash
and cash equivalents at beginning of period
|
24,405
|
10,375
|
|||||
Cash
and cash equivalents at end of period
|
$
|
33,506
|
$
|
15,709
|
Note A: |
Nature
of Business
|
Note B: |
Basis
of Presentation
|
Note C: |
Earnings
per Share Data
|
Three Months Ended
September 30
|
Nine Months Ended
September 30
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Basic
weighted-average shares
|
22,390,000
|
21,721,000
|
22,239,000
|
21,348,000
|
|||||||||
Conversion
of unsecured loan notes
|
45,000
|
46,000
|
45,000
|
46,000
|
|||||||||
Unexercised
options and warrants
|
2,334,000
|
2,356,000
|
2,434,000
|
2,651,000
|
|||||||||
Diluted
weighted-average shares
|
24,769,000
|
24,123,000
|
24,718,000
|
24,045,000
|
Note D: |
Total
Comprehensive Income
|
Three Months Ended
September 30
|
Nine Months Ended
September 30
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Comprehensive
income:
|
|||||||||||||
Net
income
|
$
|
927
|
$
|
2,060
|
$
|
2,001
|
$
|
5,368
|
|||||
Foreign
currency translation
|
48
|
10
|
63
|
84
|
|||||||||
$
|
975
|
$
|
2,070
|
$
|
2,064
|
$
|
5,452
|
Note E: |
Stock-Based
Compensation
|
2007
|
2006
|
||||||
Expected
dividend yield
|
0.00
|
%
|
0.00
|
%
|
|||
Risk-free
interest rate
|
4.49
|
%
|
4.84
|
%
|
|||
Expected
volatility
|
57.2
|
%
|
63.5
|
%
|
|||
Expected
life of option
|
5.2
years
|
5.3
years
|
Number
of
Options
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average
Remaining
Contractual
Term
|
Aggregate
Intrinsic
Value
|
||||||||||
Outstanding
on January 1, 2007
|
2,414,200
|
$
|
13.02
|
||||||||||
Granted
|
279,500
|
26.15
|
|||||||||||
Exercised
|
(179,875
|
)
|
4.83
|
$
|
4,209
|
||||||||
Expired
or forfeited
|
(62,000
|
)
|
19.81
|
||||||||||
Outstanding
on September 30, 2007
|
2,451,825
|
$
|
14.94
|
7.9
years
|
$
|
36,634
|
|||||||
Exercisable
on September 30, 2007
|
642,825
|
$
|
7.36
|
5.8
years
|
$
|
4,729
|
|||||||
Weighted-average
fair value of options granted during the nine months ended September
30,
2007
|
$
|
14.20
|
Nonvested Stock
Outstanding
|
||||
Outstanding
on January 1, 2007
|
1,702,750
|
|||
Granted
|
279,500
|
|||
Released
|
(111,250
|
)
|
||
Expired
or forfeited
|
(62,000
|
)
|
||
Outstanding
on September 30, 2007
|
1,809,000
|
Note F: |
Debt
|
Note G: |
Business
Segment and Geographic
Disclosures
|
Three months ended
September 30, 2007
|
|
Nitrogen Oxide
Reduction
|
|
Fuel Treatment
Chemical
|
|
Other
|
|
Total
|
|
||||
Net
sales from external customers
|
$
|
6,868
|
$
|
8,378
|
$
|
-
|
$
|
15,246
|
|||||
Cost
of sales
|
3,906
|
4,105
|
7
|
8,018
|
|||||||||
Gross
margin
|
2,962
|
4,273
|
(7
|
)
|
7,228
|
||||||||
Selling,
general and administrative
|
-
|
-
|
5,656
|
5,656
|
|||||||||
Research
and development
|
-
|
-
|
541
|
541
|
|||||||||
Operating
income (loss)
|
$
|
2,962
|
$
|
4,273
|
$
|
(6,204
|
)
|
$
|
1,031
|
Three months ended
September 30, 2006
|
|
Nitrogen Oxide
Reduction
|
|
Fuel Treatment
Chemical
|
|
Other
|
|
Total
|
|
||||
Net
sales from external customers
|
$
|
11,197
|
$
|
8,976
|
$
|
-
|
$
|
20,173
|
|||||
Cost
of sales
|
6,270
|
3,730
|
42
|
10,042
|
|||||||||
Gross
margin
|
4,927
|
5,246
|
(42
|
)
|
10,131
|
||||||||
Selling,
general and administrative
|
-
|
-
|
6,106
|
6,106
|
|||||||||
Research
and development
|
-
|
-
|
617
|
617
|
|||||||||
Operating
income (loss)
|
$
|
4,927
|
$
|
5,246
|
$
|
(6,765
|
)
|
$
|
3,408
|
Nine months ended
September 30, 2007
|
|
Nitrogen Oxide
Reduction
|
|
Fuel Treatment
Chemical
|
|
Other
|
|
Total
|
|||||
Net
sales from external customers
|
$
|
23,125
|
$
|
24,593
|
$
|
-
|
$
|
47,718
|
|||||
Cost
of sales
|
13,678
|
12,304
|
76
|
26,058
|
|||||||||
Gross
margin
|
9,447
|
12,289
|
(76
|
)
|
21,660
|
||||||||
Selling,
general and administrative
|
-
|
-
|
18,125
|
18,125
|
|||||||||
Research
and development
|
-
|
-
|
1,652
|
1,652
|
|||||||||
Operating
income (loss)
|
$
|
9,447
|
$
|
12,289
|
$
|
(19,853
|
)
|
$
|
1,883
|
Nine months ended
September 30, 2006
|
|
Nitrogen Oxide
Reduction
|
|
Fuel Treatment
Chemical
|
|
Other
|
|
Total
|
|
||||
Net
sales from external customers
|
$
|
36,717
|
$
|
20,336
|
$
|
-
|
$
|
57,053
|
|||||
Cost
of sales
|
20,418
|
8,658
|
134
|
29,210
|
|||||||||
Gross
margin
|
16,299
|
11,678
|
(134
|
)
|
27,843
|
||||||||
Selling,
general and administrative
|
-
|
-
|
17,569
|
17,569
|
|||||||||
Research
and development
|
-
|
-
|
1,467
|
1,467
|
|||||||||
Operating
income (loss)
|
$
|
16,299
|
$
|
11,678
|
$
|
(19,170
|
)
|
$
|
8,807
|
Three months ended September 30
|
|
Nine months ended September 30
|
|
||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Net
sales:
|
|||||||||||||
United
States
|
$
|
11,907
|
$
|
15,396
|
$
|
37,498
|
$
|
41,595
|
|||||
Foreign
|
3,339
|
4,777
|
10,220
|
15,458
|
|||||||||
$
|
15,246
|
$
|
20,173
|
$
|
47,718
|
$
|
57,053
|
||||||
|
September 30,
2007
|
December 31,
2006
|
|||||||||||
Assets:
|
|||||||||||||
United
States
|
$
|
61,474
|
$
|
62,190
|
|||||||||
Foreign
|
6,838
|
3,470
|
|||||||||||
$
|
68,312
|
$
|
65,660
|
Note H: |
Contingencies
|
(in
thousands)
|
2007
|
|||
Aggregate
product warranty liability at beginning of year
|
$
|
472
|
||
Aggregate
accruals related to product warranties
|
120
|
|||
Aggregate
reductions for payments
|
(90
|
)
|
||
Aggregate
product warranty liability at September 30, 2007
|
$
|
502
|
Note I: |
Recent
Accounting Pronouncements
|
Item 2. |
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
Item 3. |
Quantitative
and Qualitative Disclosures about Market
Risk
|
Item 4. |
Controls
and Procedures
|
Item 1. |
Legal
Proceedings
|
Item 1A. |
Risk
Factors
|
Item 2. |
Unregistered
Sales of Equity Securities and Use of
Proceeds
|
Item 3. |
Defaults
upon Senior Securities
|
Item 4. |
Submission
of Matters to a Vote of Security
Holders
|
Item 5. |
Other
Information
|
Item 6. |
Exhibits
|
a. |
Exhibits
|
Date:
November 6, 2007
|
By:
|
/s/
John F. Norris Jr.
|
John
F. Norris Jr.
|
||
Director, President and Chief Executive Officer
|
Date:
November 6, 2007
|
By:
|
/s/
Vincent J. Arnone
|
Vincent J. Arnone Chief Financial
Officer,
|
||
Sr. Vice President and Treasurer
|